Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy

Autor: Claudio Botti, Maria Benevolo, Girolamo Del Monte, Simonetta Buglioni, Stefania Vasselli, Patrizia Vici, Paola Papaldo, Marcella Mottolese, Franco Di Filippo, Cecilia Nisticò
Rok vydání: 2000
Předmět:
Zdroj: Journal of Cancer Research and Clinical Oncology. 126:722-729
ISSN: 0171-5216
Popis: Purpose: Adjuvant therapy has become an integral component of the management of primary high-risk breast cancer patients. However, a considerable fraction of women receive no benefit from this treatment. This study investigates whether a number of biopathological factors can influence the outcome of patients submitted to adjuvant chemotherapy involving the use of high-dose epirubicin and cyclophosphamide. Methods: One hundred and fifty-seven primary breast cancer patients, considered at high risk according to the St. Gallen Meeting Consensus Conference, were evaluated immunohistochemically for estrogen, progesterone receptors, p53, bcl-2, HER-2/neu, and Ki-67, of which the results were correlated with patient outcome. Results: Results obtained demonstrated that p53 is a significant predictor of disease-free survival (DFS P
Databáze: OpenAIRE